FREELINE THERAPEUTICS HLDGS - SPONSORED ADS (FRLN)

CUSIP: 35655L107

Q1 2023 13F Holders as of 31 Mar 2023

Type / Class
Equity / SPONSORED ADS
Total 13F shares
36,854,489
Share change
-1,203,306
Total reported value
$16,904,846
Price per share
$0.46
Number of holders
15
Value change
-$555,491
Number of buys
4
Number of sells
8

Quarterly Holders Quick Answers

What is CUSIP 35655L107?
CUSIP 35655L107 identifies FRLN - FREELINE THERAPEUTICS HLDGS - SPONSORED ADS in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of FREELINE THERAPEUTICS HLDGS - SPONSORED ADS (FRLN) as of Q1 2023

As of 31 Mar 2023, FREELINE THERAPEUTICS HLDGS - SPONSORED ADS (FRLN) was held by 15 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 36,854,489 shares. The largest 10 holders included Syncona Portfolio Ltd, CHI Advisors LLC, EVENTIDE ASSET MANAGEMENT, LLC, TFG Asset Management GP Ltd, UBS Group AG, RENAISSANCE TECHNOLOGIES LLC, MORGAN STANLEY, MILLENNIUM MANAGEMENT LLC, CITADEL ADVISORS LLC, and HARBOR CAPITAL ADVISORS, INC.. This page lists 15 institutional shareholders reporting positions in this security for the Q1 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.